2m 2m 2m 2m 2m 2m 2m
XBiotech (XBIT)
NASDAQ
$2.33-$0.005 (-0.21%)
Price as of Jun 23, 2026 4:10 PM EDT- $70.4MMarket Cap
- -12.73%1-Year Change
- BiotechnologyIndustry
XBiotech (XBIT)
$2.33-$0.005 (-0.21%)
XBIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.33 | ||
Change | +$0.02 (+0.87%) | ||
Open | $2.31 | ||
High | $2.35 | ||
Low | $2.30 | ||
Previous Close | $2.31 | ||
Volume | 39,388 | ||
30-Day Average Volume | 30,656 | ||
1-Week Change | -0.85% | ||
1-Month Change | -4.12% | ||
1-Year Change | -12.73% | ||
3-Year Change | -61.42% | ||
5-Year Change | -83.91% | ||
Fundamentals | |||
Shares Outstanding | 30.5M | ||
Total Assets | $139.8M | ||
Market Cap | $70.4M | ||
Enterprise Value | -$45.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$9.0M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $114.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | 9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/15/2021 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield